FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/032149 [Registered on: 19/03/2021] Trial Registered Prospectively
Last Modified On: 08/01/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [safety and efficacy]  
Study Design  Other 
Public Title of Study   Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema. 
Scientific Title of Study   An Open-label, Single Centre Study, to Determine the Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
C3B00741, Ver#01, Dated 02 Mar 21  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Dr Parth Joshi 
Designation  Principal Investigator 
Affiliation  Cliantha Research 
Address  Consumer Research Department Garden View Corporate House No 7 Opp Auda Garden Bodakdev Ahmedabad 380054 India Phone 91 79 68221100 Fax 91 79 66219549

Ahmadabad
GUJARAT
380054
India 
Phone  8000085049  
Fax  07966219549  
Email  pjoshi@cliantha.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr Parth Joshi 
Designation  Principal Investigator 
Affiliation  Cliantha Research 
Address  Consumer Research Department Garden View Corporate House No 7 Opp Auda Garden Bodakdev Ahmedabad 380054 India Phone 91 79 68221100 Fax 91 79 66219549

Ahmadabad
GUJARAT
380054
India 
Phone  8000085049  
Fax  07966219549  
Email  pjoshi@cliantha.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Dr Simran Sethi 
Designation  Director Consumer Research 
Affiliation  Cliantha Research  
Address  Consumer Research Department Garden View Corporate House No 7 Opp Auda Garden Bodakdev Ahmedabad 380054 India Phone 91 79 68221100 Fax 91 79 66219549

Ahmadabad
GUJARAT
380054
India 
Phone  9825784942  
Fax  07966219549  
Email  ssethi@cliantha.com  
 
Source of Monetary or Material Support  
Not Applicable 
 
Primary Sponsor  
Name  Wipro Manufacturing Services Sdn Bhd 
Address  Wipro Manufacturing Services Sdn. Bhd. No. 7 Persiaran Subang Permai, Taman Perindustrian Subang 47610 Selangor Darul Ehsan, Malaysia. Phone: (603) 56315588 Fax: (603) 56311778  
Type of Sponsor  Other [Personal Care Industry] 
 
Details of Secondary Sponsor  
Name  Address 
Not applicable  Not Applicable  
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parth Joshi  Cliantha Research   Consumer Research Department Garden View Corporate House No 7 Opp Auda Garden Bodakdev Ahmedabad 380054 India Phone 91 79 68221100 Fax 91 79 66219549
Ahmadabad
GUJARAT 
8000085049
07966219549
pjoshi@cliantha.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Riddhi Medical Nursing Home Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L208||Other atopic dermatitis. Ayurveda Condition: Not Applicable,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Body Lotion  Subjects will be instructed to apply pea‐sized amount of test product twice a day for each eczema site on their body to moisturize the test skin site 
Intervention  Body Wash  Subjects will be instructed to use body wash externally. Wet body, apply the 4 to 5 pumps (approximately 5 g) amount of Body Wash. Lather and rinse well. Use Once Daily for 28 consecutive days. 
Comparator Agent  Not Applicable  Not Applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1. Age: 18 to 65 years (both inclusive) old healthy, non-pregnant, and non-lactating female at the time of consent.
2. Females who have childbearing potential should have a negative urine pregnancy test at the time of the screening visit.
3. Mild to Moderate Eczema determined by Eczema Area and Severity Index (EASI) score on screening visit. [Subjects with moderate erythema (Redness: score 2) and mild scratch mark (Scratching: score 1) will be enrolled in the study].
4. Subjects with at least two active lesions on feet/face/hands or any part of the body.
5. Subjects have only a few or no pigmentation on the selected test site.
6. The subject’s in general good health as determined by Investigator based on medical history.
7. Subjects must agree to refrain from shower/bath or generally wet their skin within 3 hours before scheduled study visits.
8. Subjects must agree to wear loose clothing to allow easy exposure to the entire body during study visits.
9. Subjects must be able to understand and provide written informed consent to participate in the study.
10. Subjects should be willing and able to follow the study protocol to participate in the study.
 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Selection of unaffected and affected test sites by the dermatologist using instrument evaluations.
2. Calculation of eczema area by dermatologist using Eczema Area and Severity Index (EASI).
 
1. On Day 01 before application and on Day 14 and Day 28 after product usage
2. On Day 01 before application and Day 14 and Day 28 after product usage
 
 
Secondary Outcome  
Outcome  TimePoints 
1. cutaneous tolerance/ local irritation i.e. Erythema, Oedema, Dryness, Flaking, Scaling, Itching, Peeling, Pigmentation for body wash and body lotion
2. Global Assessment Scale (IGA) for body wash and body lotion
3. itchiness of skin using Itch NRS scale for body lotion
4. subjective self-assessment i.e. perceived symptoms of irritation such as Burning, Itching, and Stinging for body wash and body lotion
5. subjective perception about product for body wash and body lotion
 
1. On Day 01, Day 14 and Day 28
2. On Day 01, Day 14 and Day 28
3. Day 01 i.e. Baseline, 0 sec before application, to 10 sec, 20 sec, 30 sec, 40 sec, 50 sec, 60 sec, 2 min, 5 min, 10 min and 15 min after application on Day 01.

4. On Day 01, Day 14 and Day 28
5. On Day 14 and Day 28
 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "22"
Final Enrollment numbers achieved (India)="22" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/03/2021 
Date of Study Completion (India) 01/11/2021 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="28" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not Applicable 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The objective of this study is to evaluate the efficacy of body lotion on Eczema symptoms improvement in female subjects with mild to moderate eczema in a 4-week home use test.

For this study, compatibility means that the Test product does not worsen the skin condition, determined by an assessment of the lesional and non-lesional skin sites, also cutaneous tolerance of body lotion on Eczema skin will be assessed.

 
Close